St John of God Hospital in Dublin has said it is the first hospital in Ireland to introduce a special treatment for patients ...

A new non-invasive treatment for depression, which has been shown to deliver remission for one third of its patients, is to ...

Some of our patients often tell us they need to experience some undesirable truth first-hand to believe it. Implied is the ...

Bright Minds Biosciences has developed a unique platform of highly selective serotonergic agonists exhibiting selectivity at ...

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...

Shares of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP – Get Free Report) rose 4.4% on Monday . The company traded as high as $2.42 and last traded at $2.38. Approximately 188,765 shares were traded during ...

We recently compiled a list of the 12 Best Performing Small Cap Stocks So Far in 2025. In this article, we are going to take ...

OCD is often misdiagnosed or presumably not diagnosed at all. Even within the umbrella of OCD, different subtypes have ...

Ketamine has shown promise in treating major depression, but its safety for patients with both social isolation and alcohol ...

Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...

For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associate ...

New research suggests that antidepressants can accelerate cognitive decline in people with dementia. At the same time, some ...